Skip to Main Content
Skip Nav Destination
ABC

Adenosine triphosphate (ATP)-binding cassette transporter (gene superfamily)

ABCB

ATP-binding cassette gene subfamily B

ABCB1

Gene encoding MDR1 or P-gp

ABCB11

Gene encoding BSEP

ABCC

ATP-binding cassette gene subfamily C

ABCC2

Gene encoding MRP2

ABCG

ATP-binding cassette gene subfamily G

ABCG2

Gene encoding BCRP

ADE

Absorption, distribution and elimination

ADME

Absorption, distribution, metabolism and elimination

ADMET

Absorption, distribution, metabolism, elimination and toxicity

ADR

Adverse drug reaction

AhR

Aryl hydrocarbon receptor

AMP

Adenosine monophosphate

API

Active pharmaceutical ingredient

ARNT

Aryl hydrocarbon nuclear translocator

ASBT

Apical sodium dependent bile acid transporter

ATP

Adenosine triphosphate

AUC

Area under curve

AUMC

Area under the first order moment curve

BA

Bioavailability

BBB

Blood–brain barrier

BCRP

Breast cancer resistance protein (gene ABCG2)

BCS

Biopharmaceutics classification system

BCSFB

Blood–cerebrospinal fluid barrier

BDDCS

Biopharmaceutics drug disposition classification system

BEI

Biliary excretion index

BLEC

Brain like endothelial cell

BRB

Blood Retinal Barrier

BSEP

Bile salt export pump (gene ABCB11)

Caco-2

human colon adenocarcinoma cell line

CAR

Constitutive androstane receptor (NR1I3)

CCK8

Cholecystokinin-8

CDF

5-(and-6)-carboxy-2′,7′-dichloro-fluorescein

CFTR

Cystic fibrosis transmembrane conductance regulator

CHMP

Committee for Medicinal Products for Human Use

CHO

Chinese hamster ovary (cell line)

ciPTEC

Conditionally immortalized proximal tubule epithelial cells

CIS-RR

Clash-detection guided iterative search with rotamer relaxation

CL or Cl

Clearance

CLae

Apical efflux clearance

CLbile

Biliary clearance

CLd

Diffusional clearance

CLefflux

Active basolateral efflux clearance

CLi/CLo

Diffusional clearance in (i) or out (o) of the membrane

CLint

Intrinsic clearance

CLpassive

Passive clearance

CLren

Renal clearance

CLuptake

Active uptake clearance

Cmax

Maximum observed blood concentration of drug

Cmedia

Substrate media concentration

CNS

Central nervous system

CNT

Concentrative nucleoside transporters (SLC28A subfamily)

CNV

Copy number variation

Co-med

Concurrent medication

CMVs

Canalicular membrane vesicles

CoMFA

Comparative molecular analysis

CoMSIA

Comparative molecular similarity indices analysis

COPD

Chronic obstructive pulmonary disease

CP

Choroid Plexus

CRISPR

Cluster regularly interspaced short palindromic repeats

CS

Candidate selection

CsA

Cyclosporine A

CSF

Cerebrospinal fluid

CT

Computed tomography

CTA

Clinical trial application

CTD

Common technical document

CYP(450)

Cytochrome P450

CYP3A4

Cytochrome P450 3A4

DCE-MRI

Dynamic contrast-enhanced magnetic resonance imaging

DDI

Drug–drug interaction

DIA

data independent acquisition

DILI

Drug induced liver injury

DME

Drug metabolizing enzyme

DMPK

Drug metabolism and pharmacokinetics

DNA

Deoxyribonucleic acid

DRM

Drug related material

ECM

Extracellular matrix

EMA

European Medicines Agency

ENT

Equilibrative nucleoside transporter (subfamily SLC29A)

E17βG

Estradiol-17β-glucuronide

ER

Endoplasmic reticulum

ESC

Embryonic stem cell

E1S

Estrone-1-sulfate

EGTA

ethylene glycol tetraacetic acid

ENT

Equilibrative nucleoside transporter (SLC29A subfamily)

F

Bioavailability

Fa

Fraction of the dose that is absorbed from the intestinal lumen to the intestinal enterocytes

Fg

Fraction of the dose that escapes pre-systemic intestinal first pass elimination

FAH

Fumarylacetoacetate hydrolase

FBS

Foetal bovine serum

FaSSIF

Fasted state simulated intestinal fluid

FeSSIF

Fed state simulated intestinal fluid

(US) FDA

(United States) Food and Drugs Administration

fa

Fraction of dose absorbed

fm

Fraction metabolized

ft

Fraction transported

FTIH

First time in human

fu

Fraction unbound

fub

Fraction unbound in blood

FXR

Farnesoid X receptor (NR1H4)

GFJ

Grape fruit juice

GFR

Glomerular filtration rate

GI tract/GIT

Gastro-intestinal tract

GLUT

Glucose transporter

GMO

Genetically modified organism

GR

glucocorticoid receptor (NR3C1)

GSH

Glutathione (reduced state)

GST

Glutathione S-transferase enzyme

HEK293

Human embryonic kidney cells

HIV

Human immunodeficiency virus

HGNC

Human Genome Organisation Gene Nomenclature Committee

HMG-CoA

3-Hydroxy-3-methyl-glutaryl-Coenzyme A reductase

HNF4α

Hepatic nuclear factor 4alpha (NR2A1)

HUGO

Human Genome Organisation

I

Inhibitor concentration

IC50

The concentration of inhibitor required to inhibit transport by 50%

ID

injected dose

IHC

Immunohistochemistry

Iin.max

Maximum inhibitor concentration at the inlet to the liver

IND

Investigational new drug

iPSC

Induced pluripotent stem cell

IR

Immediate release

ISF

brain interstitial fluid

ITC

International Transporter Consortium

IVIVC

In vitro–in vivo correlation

IVIVE

In vitro–in vivo extrapolation

Jmax

Maximum number of APIs translocated across area per time by a given transporter

ka

Absorption rate constant of the inhibitor

Kd

dissociation constant

Ki

Inhibitory constant

Km(app)

Michaelis constant in Michaelis–Menten kinetics (apparent)

Kp

Partition coefficient

LAT

l-type amino acid transporter

LC-MS/MS

Liquid chromatography tandem mass spectrometry

LD

Lethal dose

LLC-PK1

Lilly Laboratories Culture-Pig Kidney Type 1 (cell line)

logP

logarithm of the partition coefficient, a measure of lipophilicity

LOID

Lead optimization and identification

LTC4

Leukotriene C4

LXR

Liver X receptor (NR1H3)

m/z

Mass to charge ratio

MA

Marketing authorization

MALDI

Matrix assisted laser desorption ionization

MATE

Multidrug and toxin extrusion protein

MATE1

Multidrug and toxin extrusion protein (gene SLC47A1)

MATE2

Multidrug and toxin extrusion protein (gene SLC47A2)

MCT

Monocarboxylic acid transporter

MDCK

Madin Darby canine kidney (cell line)

MDCK II

Madin Darby canine kidney, type II (cell line)

MDR

Multidrug resistance protein

MDR1

Multidrug resistance protein 1 (also known as P-gp, gene ABCB1)

MHLW

Ministry of Health, Labour and Welfare

MMP

Matrix metalloproteinases

MPP+

1-methyl-4-phenylpyridinium

MQAPs

Model quality assessment programmes

mRNA

Messenger riboxynucleic acid

MRI

Magnetic resonance imaging

MRP

Multidrug resistance associated protein

MRP2

Multidrug resistance associated protein 2 (gene ABCC2)

MRP4

Multidrug resistance associated protein 4 (gene ABCC4)

MW

Molecular weight

NaDC3

Sodium dependent dicarboxylate transporter 3 (SLC13A3)

NAT

N-acetyltransferase

NBD

Nucleotide binding domain

NCE

New chemical entity

NDA

New drug application

NIR

Near infrared imaging

NME

New molecular entity

NMR

Nuclear magnetic resonance

NPT4

Sodium phosphate transporter 4

NR

Nuclear receptor

NSAID

Non-steroidal anti-inflammatory drug

NSF

Nephrogenic systemic fibrosis

NT

Nutrient transporter

NTBC

2-(2-nitro-4-fluoro-methylbenzoyl)-1,3-cyclohexanedione

NTCP

Na-taurocholate co-transporting polypeptide

NumHBA

Number of hydrogen bond acceptors

NumHBD

Number of hydrogen bond donors

OAT

Organic anion transporter

OAT1

Organic anion transporter 1 (gene SLC22A6)

OAT3

Organic anion transporter 3 (gene SLC22A8)

OATP

Organic anion transporting polypeptide

OATP1A2

Organic anion transporting polypeptide 1A2 (gene SLCO1A2)

OATP1B1

Organic anion transporting polypeptide 1B1 (gene SLCO1B1)

OATP1B3

Organic anion transporting polypeptide 1B3 (gene SLCO1B3)

OATP2B1

Organic anion transporting polypeptide 2B1 (gene SLCO2B1)

OCT

Organic cation transporter

OCT1

Organic cation transporter (gene SLC22A1)

OCT2

Organic cation transporter (gene SLC22A2)

OCTN

Organic cation/carnitine transporter

OCTN1

Organic cation/carnitine transporter 1 (gene SLC22A4)

OCTN2

Organic cation/carnitine transporter 2 (gene SLC22A5)

OSTα/β

Organic solute transporter α/β (gene SLC51A/B)

Papp

Apparent permeability studied in vitro

PAMPA

Parallel artificial membrane permeability assay

PBEC

Porcine brain endothelial cell

PBPK

Physiologically based pharmacokinetic

Pcar

saturable carrier-mediated permeability

PCR

Polymerase chain reaction

PD

Pharmacodynamics

PDB

Protein Data Bank

Pdiff

passive diffusion

PDUFA

Prescription Drug User Fee Act

PDMS

Polydimethylsiloxane

PEff,man

Effective permeability in humans studied in vivo

PEPT

Peptide transporter

PEPT1

Peptide transporter 1 (gene SLC15A1)

PEPT2

Peptide transporter 2 (gene SLC15A2)

PET

Positron emission tomography

P-gp

P-glycoprotein (also known as MDR1, gene ABCB1)

PK

Pharmacokinetics

PK/PD

Pharmacokinetics/pharmacodynamics

PMDA

Pharmaceuticals and Medical Devices Agency (Japan)

POC or PoC

Proof of concept

Ppas

Passive diffusional driven permeability

PPAR

Peroxisome proliferator activated receptor

PSbile

Intrinsic biliary clearance

PSeff

Intrinsic sinusoidal efflux clearance

PSinf

Intrinsic uptake clearance

PXR

Pregnane X receptor (NR1I2)

QH

Hepatic blood flow

QSAR

Quantitative structure–activity relationship

QWBA

Quantitative Whole Body Autoradiography

R&D

Research and development

RAF

relative activity factor

rag

Recombinant activating gene

RBE

Rat brain endothelial

rBSEP

Rat bile salt export pump (gene ABCB11)

RCSB

Research Collaboratory for Structural Bioinformatics

REF

Relative expression factor

ROC

Receiver operating characteristics

RPTEC

Renal proximal tubule epithelial cells

RT-PCR

Reverse transcriptase polymerase chain reaction

RXR

Retinoid X receptor

SCH

Sandwich-cultured hepatocytes

SCHH

Sandwich-cultured human hepatocytes

SCID

Severe combined immunodeficiency

SERT

Serotonin transporter

SF

Scaling factor

SGLT

Sodium glucose linked transporter

SLC

Solute carrier gene superfamily

SLCO

Solute carrier organic anion transporter gene subfamily

SLC22

Solute carrier subfamily 22

SLC47

Gene encoding MATE

SLCO1A2

Gene encoding OATP1A2

SLCO1B1

Gene encoding OATP1B1

SLCO1B3

Gene encoding OATP1B3

SLCO2B1

Gene encoding OATP2B1

SLC10A1

Gene encoding NTCP

SLC15A1

Gene encoding PEPT1

SLC15A2

Gene encoding PEPT2

SLC22A1

Gene encoding OCT1

SLC22A2

Gene encoding OCT2

SLC22A4

Gene encoding OCTN1

SLC22A5

Gene encoding OCTN2

SLC22A6

Gene encoding OAT1

SLC22A8

Gene encoding OAT3

SLC28A

Gene encoding CNT

SLC29A

Gene encoding ENT

SLC51A/B

Gene encoding OSTα/β

S log P

estimate of logP by summing the contribution of atom-weighted solvent accessible surface areas (SASA) and correction factors

SMR

Molar refractivity (including implicit hydrogens). This property is an atomic contribution model that assumes the correct protonation state (washed structures).

SNP(s)

Single nucleotide polymorphism(s)

SPECT

Single photon emission computed tomography

SRM

Selected reaction monitoring

SULT

Sulfotransferase enzyme

TALEN

Transcription activator-like effector nuclease

TCDB

Transporter classification database

TCDD

2,3,7,8-Tetrachlorodibenzo-p-dioxin

TEA

Tetraethylammonium

TEER

Transepithelial electrical resistance

TK

Toxicokinetics

Tmax

Time at which the Cmax is observed

TMD

Trans-membrane domain

TPSA

Topological polar surface area

UDP

Uridine 5′-diphosphate

UGT

Uridine 5′-diphospho-glucuronosyltransferase or UDP-glucuronosyltransferase

URAT

Urate transporter

VD or Vd

Volume of distribution

Vmax

Maximal velocity

ZFN

Zinc-finger nucleases

Close Modal

or Create an Account

Close Modal
Close Modal